These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14968810)

  • 1. AACR-NCI-EORTC-15th symposium molecular targets and cancer therapeutics: emerging targets and pharmacodynamics.
    Mayfield R
    IDrugs; 2004 Jan; 7(1):22-5. PubMed ID: 14968810
    [No Abstract]   [Full Text] [Related]  

  • 2. AACR-NCI-EORTC-15th symposium molecular targets and cancer therapeutics: enzyme inhibitors and anti-angiogenics.
    Mayfield R
    IDrugs; 2004 Jan; 7(1):19-21. PubMed ID: 14968809
    [No Abstract]   [Full Text] [Related]  

  • 3. AACR-NCI-EORTC--17th symposium: Molecular targets and cancer therapeutics. Emerging targets and new agents from academia. 14-18th November 2005, Philadelphia, PA, USA.
    Garvey R
    IDrugs; 2006 Jan; 9(1):6-8. PubMed ID: 16374722
    [No Abstract]   [Full Text] [Related]  

  • 4. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 2.
    Searle B; Collins T
    IDrugs; 2007 Dec; 10(12):836-9. PubMed ID: 18041674
    [No Abstract]   [Full Text] [Related]  

  • 5. AACR-NCI-EORTC--17th symposium: Molecular targets and cancer therapeutics. Drug highlights. 14-18th November 2005, Philadelphia, PA, USA.
    Garvey R
    IDrugs; 2006 Jan; 9(1):9-12. PubMed ID: 16374723
    [No Abstract]   [Full Text] [Related]  

  • 6. 14th EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics," November 19-22, 2002, Frankfurt, Germany.
    Evans AE
    Med Pediatr Oncol; 2003 Dec; 41(6):541-4. PubMed ID: 14595711
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylase.
    Budillon A; Bruzzese F; Di Gennaro E; Caraglia M
    Curr Drug Targets; 2005 May; 6(3):337-51. PubMed ID: 15857292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AACR-NCI-EORTC--17th symposium: Molecular targets and cancer therapeutics. 14-18th November 2005, Philadelphia, PA, USA.
    Veryard C
    IDrugs; 2006 Jan; 9(1):1-3. PubMed ID: 16374720
    [No Abstract]   [Full Text] [Related]  

  • 9. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 3.
    Collins T
    IDrugs; 2007 Dec; 10(12):840-3. PubMed ID: 18041675
    [No Abstract]   [Full Text] [Related]  

  • 10. AACR-NCI-EORTC--17th Symposium: Molecular Targets and Cancer Therapeutics.
    Garvey R
    IDrugs; 2006 Feb; 9(2):90-2. PubMed ID: 16523394
    [No Abstract]   [Full Text] [Related]  

  • 11. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 4.
    Eccles SA
    IDrugs; 2007 Dec; 10(12):844-7. PubMed ID: 18041676
    [No Abstract]   [Full Text] [Related]  

  • 12. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 1.
    Searle B
    IDrugs; 2007 Dec; 10(12):833-5. PubMed ID: 18041673
    [No Abstract]   [Full Text] [Related]  

  • 13. EORTC-NCI-AACR--20th symposium molecular targets and cancer therapeutics.
    Din S
    IDrugs; 2008 Dec; 11(12):855-6. PubMed ID: 19051141
    [No Abstract]   [Full Text] [Related]  

  • 14. EORTC-NCI-AACR - 18th Symposium - Molecular Targets and Cancer Therapeutics. Updates on cancer drugs.
    Kibble A
    IDrugs; 2007 Jan; 10(1):3-4. PubMed ID: 17187302
    [No Abstract]   [Full Text] [Related]  

  • 15. AACR-NCI-EORTC--17th symposium: Molecular targets and cancer therapeutics. Imaging agents, drug delivery and targeting, and drug updates. 14-18th November 2005, Philadelphia, PA, USA.
    Veryard C
    IDrugs; 2006 Jan; 9(1):4-5. PubMed ID: 16374721
    [No Abstract]   [Full Text] [Related]  

  • 16. EORTC-NCI-AACR--20th symposium molecular targets and cancer therapeutics: mechanisms of targeting for cancer treatment.
    Fakorede A
    IDrugs; 2008 Dec; 11(12):857-8. PubMed ID: 19051142
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitors of histone-deacetylases.
    Pelicci PG
    Tumori; 2001; 87(6):S12-4. PubMed ID: 11989609
    [No Abstract]   [Full Text] [Related]  

  • 18. Histone deacetylase inhibitors in cancer therapy.
    Fouladi M
    Cancer Invest; 2006; 24(5):521-7. PubMed ID: 16939962
    [No Abstract]   [Full Text] [Related]  

  • 19. EORTC-NCI-AACR--14th Symposium. Molecular targets and cancer therapeutics--part II. 19-22 November 2002, Frankfurt, Germany.
    Patterson C
    IDrugs; 2003 Jan; 6(1):27-9. PubMed ID: 12838969
    [No Abstract]   [Full Text] [Related]  

  • 20. [[Inhibitors of histone deacetylase as new agents for prevention and treatment of cancer] ].
    Jung M
    Pharm Unserer Zeit; 2000 Nov; 29(6):385-8. PubMed ID: 11199916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.